Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Juheshun Advanced Material Co., Ltd. (605166.SS)
Hangzhou, CN
Juheshun Advanced Material Co., Ltd. specializes in the entire lifecycle of polyamide materials, encompassing their research, development, manufacturing, and distribution. The company offers a diverse product portfolio, categorized into specific grades for fiber applications, engineering plastics, and films. These materials are extensively utilized across various industries, including consumer electronics, industrial machinery, food packaging, textiles, and advanced sectors like aerospace, nuclear energy, and defense. The firm was established on November 1, 2013, and its primary operations are based in Hangzhou, China.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -4.29% | -11.76% | -14.10% | -14.47% | -9.46% | -3.09% | -12.00% | +6.35% | +2.55% | -0.99% | -0.99% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2025-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Chemicals - Specialty: +4.7%-22.9% Q1'26: -24.1% (vs Q1'25)
-
EPS growth Chemicals - Specialty: +13.2%-46.5% Q1'26: -52.2% (vs Q1'25)
-
FCF margin FCF growth · Chemicals - Specialty: +44.1%-0.2% Q1'26: -7.7% (vs Q1'25)
-
EBIT margin Chemicals - Specialty: +8.8%+3.8% Q1'26: +3.6% (vs Q1'25)
-
ROIC Chemicals - Specialty: +5.6%+27.3% ★ Q1'26: +4.2% (vs Q1'25)
-
Share dilution Chemicals - Specialty: +0.1%-13.7% ★ Q1'26: -10.4% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Chemicals - Specialty: 0.18×3.41× ★ Q1'26: 19.89× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 1 Rev. Ana. 1 EPS Ana. |
Dec 2027 1 Rev. Ana. 1 EPS Ana. |
Dec 2028 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|
| Revenue |
2.56B
est: 2.29B (+12.1%)
|
5.46B
est: 4.50B (+21.2%)
|
6.04B
est: 7.03B (-14.1%)
|
6.02B
est: 6.22B (-3.2%)
|
7.17B
est: 7.01B (+2.2%)
|
5.52B
est: 5.34B (+3.4%)
|
8.12B
8.12B – 8.12B
+51.9% YoY
|
9.14B
9.14B – 9.14B
+12.6% YoY
|
12.02B
12.02B – 12.02B
+31.4% YoY
|
| EBITDA |
169.43M
est: 139.64M (+21.3%)
|
314.96M
est: 274.96M (+14.5%)
|
335.53M
est: 429.22M (-21.8%)
|
319.01M
est: 379.46M (-15.9%)
|
517.31M
est: 407.71M (+26.9%)
|
288.67M
est: 310.73M (-7.1%)
|
472.11M
472.11M – 472.11M
+51.9% YoY
|
531.71M
531.71M – 531.71M
+12.6% YoY
|
698.78M
698.78M – 698.78M
+31.4% YoY
|
| EBIT |
133.14M
est: 116.56M (+14.2%)
|
276.61M
est: 229.53M (+20.5%)
|
287.26M
est: 358.30M (-19.8%)
|
255.19M
est: 316.76M (-19.4%)
|
444.04M
est: 336.89M (+31.8%)
|
207.74M
est: 256.75M (-19.1%)
|
390.10M
390.10M – 390.10M
+51.9% YoY
|
439.34M
439.34M – 439.34M
+12.6% YoY
|
577.40M
577.40M – 577.40M
+31.4% YoY
|
| Net Income |
115.84M
est: 127.67M (-9.3%)
|
240.44M
est: 293.65M (-18.1%)
|
242.19M
est: 328.31M (-26.2%)
|
196.72M
est: 280.88M (-30.0%)
|
300.30M
est: 308.58M (-2.7%)
|
144.84M
est: 147.99M (-2.1%)
|
261.35M
261.35M – 261.35M
+76.6% YoY
|
332.20M
332.20M – 332.20M
+27.1% YoY
|
437.68M
437.68M – 437.68M
+31.8% YoY
|
| SGA |
23.28M
est: 10.10M (+130.6%)
|
36.54M
est: 19.88M (+83.8%)
|
41.84M
est: 31.03M (+34.8%)
|
48.59M
est: 27.43M (+77.1%)
|
51.04M
est: 47.90M (+6.5%)
|
29.48M
est: 36.51M (-19.2%)
|
55.47M
55.47M – 55.47M
+51.9% YoY
|
62.47M
62.47M – 62.47M
+12.6% YoY
|
82.10M
82.10M – 82.10M
+31.4% YoY
|
| EPS |
0.42
est: 0.35 (+20.0%)
|
0.76
est: 0.81 (-5.6%)
|
0.77
est: 0.90 (-14.4%)
|
0.62
est: 0.77 (-19.5%)
|
0.95
est: 0.98 (-3.1%)
|
0.46
est: 0.47 (-2.1%)
|
0.83
0.83 – 0.83
+76.6% YoY
|
1.06
1.06 – 1.06
+27.1% YoY
|
1.39
1.39 – 1.39
+31.8% YoY
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-28 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-27 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-26 | C+ | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 1/5 | 3/5 |
| 2026-05-25 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-22 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-21 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-20 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-19 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-18 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-15 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-14 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-13 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-12 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-11 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-08 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-07 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-05-06 | B- | 2/5 | 1/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-30 | B | 3/5 | 3/5 | 3/5 | 4/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-29 | B | 3/5 | 3/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-28 | B- | 3/5 | 1/5 | 3/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-27 | B- | 2/5 | 1/5 | 3/5 | 5/5 | 1/5 | 1/5 | 3/5 |
| 2026-04-24 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-23 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-22 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-21 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-20 | B | 3/5 | 1/5 | 4/5 | 5/5 | 1/5 | 2/5 | 3/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 1/5 | 2/5 | 2/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Jian Mao | Accounting Supervisor | — | — |
| Shuangyan Yao | Deputy GM, Chief Financial Officer, Secretary of the Board of Directors & Director | — | female |
| Xinhua Mao | GM & Director | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 605166.SS
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
